Subscapularis Tendon Rupture Clinical Trial
Official title:
Prospective Multicenter Trial on Diagnostics and Outcome of Ruptures of the Subscapularis After Arthroscopic Refixation
| NCT number | NCT02383914 |
| Other study ID # | Subscap-042014 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | March 2014 |
| Est. completion date | October 2018 |
| Verified date | November 2020 |
| Source | University of Rostock |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The purpose of the trial is to optimize the diagnostics of subscapularis tendon tears and as the circumstances require to found a new classification. The prime objective is a comparison of the conclusive of the clinic check-up, the sonographic and magnetic resonance tomography findings. The secondary objective is to detect the correlation of the outcome with the age , the gender, the pathogenesis and attendant injuries.
| Status | Completed |
| Enrollment | 32 |
| Est. completion date | October 2018 |
| Est. primary completion date | December 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 75 Years |
| Eligibility | Inclusion Criteria: - patients, who have turned 18 - suspected subscapularis tendon rupture Exclusion Criteria: - disability to understand the trial - intraoperative intact supbscapularis tendon - pre-surgical operation of the affected shoulder - tumor - infection |
| Country | Name | City | State |
|---|---|---|---|
| Germany | Orthopaedic Clinic of the University of Rostock | Rostock | Mecklenburg-Vorpommern |
| Lead Sponsor | Collaborator |
|---|---|
| University of Rostock |
Germany,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Shoulder function (Constant Score) | 52 weeks post- operative | ||
| Secondary | Strength | Strength will be measured by a special force sensor | 12 and 52 weeks post-operative | |
| Secondary | Rerupture Rate | Sonographic investigation of rerupture rate | 12 and 52 weeks post-operative |